Navigation Links
DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
Date:3/4/2008

RALEIGH, N.C., March 4 /PRNewswire-FirstCall/ -- DARA BioSciences(TM) (Nasdaq: DARA) announced today the appointment of David J. Drutz, MD to the Board of Directors. Dr. Drutz was appointed to fill a Board vacancy and will serve on the Company's Compensation Committee as well as Corporate Governance and Nominating Committee. The appointment was effective February 26, 2008.

Richard Franco, Sr., DARA's Board Chairman, commented, "It is a pleasure to announce David's appointment. Considering his varied background and successful experiences, David will add another positive dimension to our Board."

Dr. Drutz's background includes senior executive positions in the pharma and biotech industries. He is currently President of Pacific Biopharma Associates, LLC and a General Partner with Pacific Rim Ventures Company, Ltd. He serves as a director in both the public and private sectors, is a member of several scientific advisory boards, and holds a certificate of director education from the National Association of Corporate Directors.

About DARA BioSciences, Inc.

DARA BioSciences(TM), Inc. ("DARA") is a Raleigh, North Carolina-based development-stage pharmaceutical company that acquires promising therapeutic molecules and medical technologies directly or through investment in established companies. DARA focuses its therapeutic development efforts on small molecules from late preclinical development through phase 2 clinical trials. DARA is developing a portfolio of therapeutic candidates for neuropathic pain, metabolic diseases including type 2 diabetes, dyslipidemia and dermatological disorders. DARA has licensed promising drug development candidates from Kirin Pharmaceuticals of Japan, Bayer Pharmaceuticals Corporation, Massachusetts General Hospital and Nuada LLC.

For more information please contact the Company at 919-872-5578 or visit our web site at http://www.darabio.com.

All statements in this news release that are not historical are forward- looking statements within the meaning of the Securities Exchange Act of 1934 as amended. Such forward-looking statements are subject to factors that could cause actual results to differ materially for DARA from those projected. Those factors include risks and uncertainties relating to the company's ability to develop and bring new products to market as anticipated, the current regulatory environment in which the company develops and sells its products, the market acceptance of those products, dependence on partner, successful performance under collaborative and other commercial agreements, competition, the strength of DARA's intellectual property, the intellectual property of others and other risk factors identified in the documents DARA has filed, or will file, with the Securities and Exchange Commission. Copies of DARA's filings with the SEC may be obtained from the SEC Internet site at http://www.sec.gov. DARA expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in DARA's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. DARA BioSciences and the DARA logo are trademarks of DARA BioSciences, Inc.


'/>"/>
SOURCE DARA BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
2. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
3. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
4. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... 2017 , ... NexTec Group has been selected as a member of the ... accomplishments in the field of midmarket financial software. , Members of the VAR Stars ... is not based on revenue and those firms chosen represent a wide range of ...
(Date:1/15/2017)... (PRWEB) , ... January 15, 2017 , ... Whole Health Supply, LLC is announcing the ... There are also new avenues for purchase. , The 2017 edition has wide jaws ... issues for the older boomers as well as diabetics. This handle is reinforced for extra ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine ... Bay Area counties for 2017. Almost 1,000 nominations were submitted and a little ... process. Results were announced the magazine’s January 2017 issue . , Under ...
(Date:1/15/2017)... , ... January 15, 2017 , ... ... in Montclair, NJ is pleased to announce that it will be assisting HackensackUMC ... in Montclair and Glen Ridge townships, servicing all surrounding towns. The firm will ...
(Date:1/14/2017)... (PRWEB) , ... January 14, 2017 , ... AgileMinder develops ... , The Emoji Scale is now available on Apple as a fun, free ... ratings simply by choosing one of the ten color coded values on The Emoji ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... Jan. 13, 2017  Alfalfa, cattle, leafy greens and rosy ... sampling film , which emphasizes the food industry,s shift from ... how COPAN,s Swab Rinse Kit ... surface sampling process in the wake of the new ... COPAN is expanding the U.S. production of ...
(Date:1/13/2017)... Pa. , Jan. 13, 2017  Secretary of ... of students, professors, and community members at Misericordia University ... opioid epidemic in Pennsylvania . ... crisis I,ve seen so far in my professional career," ... has been hit hard by heroin and ...
(Date:1/13/2017)... BOISE, Idaho , Jan. 12, 2017 /PRNewswire/ ... status by Accreditation Commission for Health Care (ACHC) ... the largest national food and drug chain with ... service for pharmacy patients. Accreditation by ... meeting national standards to facilitate a higher level ...
Breaking Medicine Technology: